Skip to main content
. 2020 Jul 29;13:495–498. doi: 10.2147/CCID.S254114

Table 1.

Evidence on Long-Term Management

Active Substance (Topical) Trials Total Patients Total (n) Level of Evidence
Calcipotriol (mono only) 7 1516 7xC
Calcipotriol (combination only) 5 1600 2xA2, 3xB
Tacalcitol 4 566 4xC
Calcitriol 1 253 C
Betamethasone Dipropionate/Valerate (incl. combinations.) 6 917 2xA2, 3xB, 1xC
Clobetasol Propionate 4 277 1xA2, 3xB

Note: Data from Augustin et al.11